18 results
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:18pm
, marketing, drug development, technical and human resources than we do. Large pharmaceutical companies, in particular, have extensive experience in clinical
424B3
XRTX
XORTX Therapeutics Inc
13 Jun 24
Prospectus supplement
4:11pm
, marketing, drug development, technical and human resources than we do. Large pharmaceutical companies, in particular, have extensive experience in clinical
6-K
EX-99.3
XRTX
XORTX Therapeutics Inc
3 Apr 23
Consolidated Financial Statements
6:05am
competitors have significantly greater financial, manufacturing, marketing, drug development, technical and human resources than we do. Large pharmaceutical
424B4
fun dsjv3ot6djsyw
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
icx 98zrcg9gebi
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
35zovgtglvgjkd1mqc9
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
jiuo8 28huihdgaj
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
bympqkxn ff7
15 Aug 22
Draft registration statement
12:00am
20-F
2mn64uby246x
3 May 22
Annual report (foreign)
5:29pm
6-K
EX-99.1
k6q 520jxsre1wsay
13 Apr 22
Current report (foreign)
7:23am
424B4
p43h9vwbagay0tgmvx
14 Oct 21
Prospectus supplement with pricing info
4:30pm
F-1/A
eyphq2mqlh 5pk
4 Oct 21
Registration statement (foreign) (amended)
12:00am
F-1/A
z8jcqc 5m5gf5059b
16 Sep 21
Registration statement (foreign) (amended)
5:16pm
F-1
mptwv8p qfrifd6
11 Aug 21
Registration statement (foreign)
9:55pm
DRS/A
jnfrq113 hcdr7dvz
21 Jul 21
Draft registration statement (amended)
12:00am
DRS
gr81auclnw9m 15nt
26 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next